The challenge is that the validator sets the rules for who is vaccinated.

As an example, some jurisdictions might declare individuals with single doses protected.

Another real example: the EU is unwilling to accept Covishield vaccinations, despite it being AstraZeneca/Vaxzevria manufactured in India.